Skip to main content
Signal8

FOXO TECHNOLOGIES INC. (FOXO)

FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Care Facilities

FOXO Technologies Inc. logo

FOXO Technologies Inc.

OTC:FOXOHealthcare
+0.00%$0.1000
Mkt Cap$166K
Float1.66M
O/S1.66M
Inst Own-
SI0.2%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$165,812
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 1.66M shares outstanding

SectorHealthcare
IndustryMedical - Healthcare Information Services
ExchangeOTC
CountryUSUS
IPO DateSep 16, 2022
Shares Outstanding1.66M
Float1.66M
Company Overview

FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector.

The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures.

Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.

Leadership

Bret Barnes

Chairman and Director

Francis Colt deWolf III

Director

Mark White

Director

Martin Ward

Interim Chief Financial Officer

Employees

102

Country

US

Sector

Healthcare

Website

foxotechnologies.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
5.0%
5%+ Owners
(3)
of which 0.0% rests on schedules older than 24 months (2 holders)
95.0%
Unattributed (incl. retail)ⓘ
5%+ Beneficial5.0%
Unattributed (incl. retail)95.0%
Top Shareholders
NameShares%
SABBY MANAGEMENT, LLC logo
SABBY MANAGEMENT, LLC
· may incl. warrants· filed Jan 2026
83.1K5.0%
Rennova Health, Inc. logo
Rennova Health, Inc.
· may incl. warrants· stale · filed Sep 2024
170.0%
CLEARTHINK CAPITAL PARTNERS, LLC EIN 88-345-9534 logo
CLEARTHINK CAPITAL PARTNERS, LLC EIN 88-345-9534
· may incl. warrants· stale · filed Dec 2023
100.0%
Sources: Form 4, 13D/13GO/S: 1.7M · as of 11 Aug 2026 · SEC cover page
52-Week Range
$0.0299$7.20
$0.1000(1st percentile)
Volume
Average Daily Volume7.21K
9.03K today vs 7.21K avg(+25%)

30d Avg

7.21K

60d Avg

7.00K

90d Avg

16.42K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...